Recently seen an increasing number of patients with osteoporosis has been observed that presents as a chronic illness, particularly to the elderly female patients. It is important not only to treat pain but to follow up bone mass changes to prevent decrease in bone mass. On a measurement of bone mass in patients with osteoporosis, author has emploied the Microdensitometry (MD) method. In this study, author examined changes of bone mass and the severity of pain in patients on long-term therapy with Gui-zhi-jia-shu-fu-tang, Ipriflavone and Oxaprozine.
In 18 cases given Gui-zhi-jia-shu-fu-tang, the initial bone mass data were as follows : metacarpal-index (MCI), 0.39±0.08; bone density (ΣGS/D), 2.07±0.32. No difference or increase from the initial values after three, six and nine months of treatment was observed.
In 22 cases given Ipriflavone, the initial data were : MCI, 0.39±0.07;ΣGS/D2.07±0.33. The results obtained after three, six and nine months of treatment showed no difference or increase from the initial values.
In 11 cases given Oxaprozine, the initial MCI and ΣGS/D values were 0.40±0.06 and 2.08±0.33, respectively. Furthermore, these data were 0.36±0.05 and 1.92±0.26 after nine months, showing a significant decrease.
The severity of pain was equally reduced by treatment with Gui-zhi-jia-shu-fu-tang or Oxaprozine. However, only the bone mass in patients given Oxaprozine was decreased.
The group given Gui-zhi-jia-shu-fu-tang showed suppression of bone loss, demonstrating the effectiveness of this agent in maintaining and improving bone mass.
View full abstract